Antiretroviral therapy initiation and retention among clients who received peer-delivered linkage case management and standard linkage services, Eswatini, 2016-2020: retrospective comparative cohort study.
Africa
Cohort studies
HIV care continuum
Linkage to care
Retention
Treatment
Journal
Archives of public health = Archives belges de sante publique
ISSN: 0778-7367
Titre abrégé: Arch Public Health
Pays: England
ID NLM: 9208826
Informations de publication
Date de publication:
09 Mar 2022
09 Mar 2022
Historique:
received:
06
08
2021
accepted:
29
01
2022
entrez:
9
3
2022
pubmed:
10
3
2022
medline:
10
3
2022
Statut:
epublish
Résumé
Persons living with HIV infection (PLHIV) who are diagnosed in community settings in sub-Saharan Africa are particularly vulnerable to barriers to care that prevent or delay many from obtaining antiretroviral therapy (ART). We conducted a retrospective cohort study to assess if a package of peer-delivered linkage case management and treatment navigation services (CommLink) was more effective than peer-delivered counseling, referral, and telephone follow-up (standard linkage services, SLS) in initiating and retaining PLHIV on ART after diagnosis in community settings in Eswatini. HIV-test records of 773 CommLink and 769 SLS clients aged ≥ 15 years diagnosed between March 2016 and March 2018, matched by urban and rural settings of diagnosis, were selected for the study. CommLink counselors recorded resolved and unresolved barriers to care (e.g., perceived wellbeing, fear of partner response, stigmatization) during a median of 52 days (interquartile range: 35-69) of case management. Twice as many CommLink than SLS clients initiated ART by 90 days of diagnosis overall (88.4% vs. 37.9%, adjusted relative risk (aRR): 2.33, 95% confidence interval (CI): 1.97, 2.77) and during test and treat when all PLHIV were eligible for ART (96.2% vs. 37.1%, aRR: 2.59, 95% CI: 2.20, 3.04). By 18 months of diagnosis, 54% more CommLink than SLS clients were initiated and retained on ART (76.3% vs. 49.5%, aRR: 1.54, 95% CI: 1.33, 1.79). Peer counselors helped resolve 896 (65%) of 1372 identified barriers of CommLink clients. Compared with clients with ≥ 3 unresolved barriers to care, 42% (aRR: 1.42, 95% CI: 1.19, 1.68) more clients with 1-2 unresolved barriers, 44% (aRR: 1.44, 95% CI: 1.25, 1.66) more clients with all barriers resolved, and 54% (aRR: 1.54, 95% CI: 1.30, 1.81) more clients who had no identified barriers were initiated and retained on ART by 18 months of diagnosis. To improve early ART initiation and retention among PLHIV diagnosed in community settings, HIV prevention programs should consider providing a package of peer-delivered linkage case management and treatment navigation services. Clients with multiple unresolved barriers to care measured as part of that package should be triaged for differentiated linkage and retention services.
Sections du résumé
BACKGROUND
BACKGROUND
Persons living with HIV infection (PLHIV) who are diagnosed in community settings in sub-Saharan Africa are particularly vulnerable to barriers to care that prevent or delay many from obtaining antiretroviral therapy (ART).
METHODS
METHODS
We conducted a retrospective cohort study to assess if a package of peer-delivered linkage case management and treatment navigation services (CommLink) was more effective than peer-delivered counseling, referral, and telephone follow-up (standard linkage services, SLS) in initiating and retaining PLHIV on ART after diagnosis in community settings in Eswatini. HIV-test records of 773 CommLink and 769 SLS clients aged ≥ 15 years diagnosed between March 2016 and March 2018, matched by urban and rural settings of diagnosis, were selected for the study. CommLink counselors recorded resolved and unresolved barriers to care (e.g., perceived wellbeing, fear of partner response, stigmatization) during a median of 52 days (interquartile range: 35-69) of case management.
RESULTS
RESULTS
Twice as many CommLink than SLS clients initiated ART by 90 days of diagnosis overall (88.4% vs. 37.9%, adjusted relative risk (aRR): 2.33, 95% confidence interval (CI): 1.97, 2.77) and during test and treat when all PLHIV were eligible for ART (96.2% vs. 37.1%, aRR: 2.59, 95% CI: 2.20, 3.04). By 18 months of diagnosis, 54% more CommLink than SLS clients were initiated and retained on ART (76.3% vs. 49.5%, aRR: 1.54, 95% CI: 1.33, 1.79). Peer counselors helped resolve 896 (65%) of 1372 identified barriers of CommLink clients. Compared with clients with ≥ 3 unresolved barriers to care, 42% (aRR: 1.42, 95% CI: 1.19, 1.68) more clients with 1-2 unresolved barriers, 44% (aRR: 1.44, 95% CI: 1.25, 1.66) more clients with all barriers resolved, and 54% (aRR: 1.54, 95% CI: 1.30, 1.81) more clients who had no identified barriers were initiated and retained on ART by 18 months of diagnosis.
CONCLUSIONS
CONCLUSIONS
To improve early ART initiation and retention among PLHIV diagnosed in community settings, HIV prevention programs should consider providing a package of peer-delivered linkage case management and treatment navigation services. Clients with multiple unresolved barriers to care measured as part of that package should be triaged for differentiated linkage and retention services.
Identifiants
pubmed: 35260189
doi: 10.1186/s13690-022-00810-9
pii: 10.1186/s13690-022-00810-9
pmc: PMC8905856
doi:
Types de publication
Journal Article
Langues
eng
Pagination
74Informations de copyright
© 2022. The Author(s).
Références
Gates Open Res. 2020 Jul 29;4:116
pubmed: 32875281
AIDS Behav. 2018 Mar;22(3):722-732
pubmed: 28643242
AIDS Care. 2021 Jan;33(1):70-79
pubmed: 32036678
J Int AIDS Soc. 2020 Jul;23(7):e25560
pubmed: 32618137
PLoS One. 2016 Feb 24;11(2):e0150086
pubmed: 26910847
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
EBioMedicine. 2017 Mar;17:163-171
pubmed: 28161401
PLoS One. 2018 Apr 19;13(4):e0195127
pubmed: 29672542
J Int AIDS Soc. 2018 Feb;21(2):
pubmed: 29479867
AIDS. 2012 Oct 23;26(16):2059-67
pubmed: 22781227
J Int AIDS Soc. 2020 Sep;23(9):e25610
pubmed: 32949103
Lancet HIV. 2017 May;4(5):e223-e230
pubmed: 28153470
Trop Med Int Health. 2019 Jun;24(6):701-714
pubmed: 30938037
J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):432-438
pubmed: 28060226
J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):527-535
pubmed: 29771786
PLoS One. 2018 Jul 27;13(7):e0200737
pubmed: 30052637
AIDS Behav. 2021 May;25(5):1518-1531
pubmed: 32780187
PLoS One. 2018 Dec 13;13(12):e0208919
pubmed: 30543693
J Acquir Immune Defic Syndr. 2015 May 1;69(1):98-108
pubmed: 25942461
J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25120
pubmed: 30027651
AIDS Behav. 2016 Oct;20(10):2452-2463
pubmed: 26837630
Trop Med Int Health. 2015 Jul;20(7):893-902
pubmed: 25753897
HIV Med. 2019 Nov;20(10):704-708
pubmed: 31454139
PLoS Med. 2021 Oct 18;18(10):e1003831
pubmed: 34662333
J Int AIDS Soc. 2016 Jun 28;19(1):20929
pubmed: 27357495
PLoS One. 2020 Apr 28;15(4):e0231952
pubmed: 32343742
PLoS Med. 2018 Jun 11;15(6):e1002589
pubmed: 29889844
PLoS Med. 2017 May 2;14(5):e1002292
pubmed: 28464041